Traders on Wall Street have gone wild over online restaurant reservation system OpenTable, rewarding it with a price/earnings ratio as high as 130. That's the kind of valuation you'd expect to see for a company that has discovered a cure for cancer, not one that enables people to book a seat at, say, Buca di Beppo or one of the many other restaurants in its network. While OpenTable seems to work well for most full-service restaurants that participate, a few operators have begun to question ...
Register to view this article
Registering for Premium Content on Restaurant Hospitality will give youINSTANTaccess to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’sFREE, easy and quick.